Healthcare IT Today

MARCH 23, 2023

To tap into the potential of protein-level data, Protai has built a proteomics AI-based platform that comprehensively maps the course of a disease on the protein level. Its technology allows it to better predict which patients will respond to a given drug, as well as discover novel drug targets that were missed by genomic approaches. “We

Drug Development 77

Drug Development BioTech Health IT Healthcare IT 77

Lloyd Price

NOVEMBER 21, 2023

Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Of course, there are also some risks associated with Palantir buying a healthcare company. This allows clinicians to be proactive in their treatment, and to prevent problems before they occur.

Drug Development 68

Drug Development Health science healthcare technology Leadership 68

Lloyd Price

MAY 16, 2023

Overall, Palantir's software is helping to improve patient care, accelerate research, and improve drug development. Of course, there are also some risks associated with Palantir buying a healthcare company. This allows clinicians to be proactive in their treatment, and to prevent problems before they occur. Have a comment?

Drug Development 90

Drug Development Health science Pharmaceuticals Public Health 90

Healthcare IT Today

JANUARY 9, 2023

It would be incredibly valuable, for instance, to be able to run a structured query against a collection of images sitting in BLOB storage, and pull out every example showing a concerning mass in a particular part of the patient’s body that’s consistent with the others in order to determine the best course for treatment.

Health IT 94

Health IT Pharmaceuticals Drug Development Life Science 94

Lloyd Price

FEBRUARY 20, 2020

Interestingly, the future of DTx may lie in cooperation rather than in competition with Big Pharma and drug development. There is, of course, a considerable change in mindset required to leverage the full potential of AI and Big Data.

mHealth 81

mHealth Drug Development Digital Health 81

Xealth

JUNE 27, 2023

Its interest in DTx exists specifically in remote patient monitoring because of the potential to provide valuable insights throughout drug development life cycles. Systems that aren’t gauging DTx efficacy now will be several steps behind their competitors when the industry gains surer footing and regulations continue to develop.

Digital Health 52

Digital Health Drug Development Pharmaceuticals EHR 52

Insulin Nation

MAY 16, 2019

I drank water and took insulin, enough to get it down over the course of the night. Economics of Development and Marketing. Ritz and McDevitt estimate that it will take $35 million to fund drug development through Phase III trials and FDA submission.

Drug Development 53

Drug Development 53